Sydnor, Valerie J.
Larsen, Bart
Seidlitz, Jakob https://orcid.org/0000-0002-8164-7476
Adebimpe, Azeez
Alexander-Bloch, Aaron F. https://orcid.org/0000-0001-6554-1893
Bassett, Dani S. https://orcid.org/0000-0002-6183-4493
Bertolero, Maxwell A. https://orcid.org/0000-0002-2691-3698
Cieslak, Matthew https://orcid.org/0000-0002-1931-4734
Covitz, Sydney
Fan, Yong https://orcid.org/0000-0001-9869-4685
Gur, Raquel E.
Gur, Ruben C.
Mackey, Allyson P.
Moore, Tyler M. https://orcid.org/0000-0002-1384-0151
Roalf, David R. https://orcid.org/0000-0002-1728-9782
Shinohara, Russell T.
Satterthwaite, Theodore D. https://orcid.org/0000-0001-7072-9399
Funding for this research was provided by:
National Science Foundation (DGE-1845298)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (K99MH127293, T32MH014654, K08MH120564, R01MH113550, RF1MH116920, R01MH119219, R01MH119219, R01MH119185, R01MH120174, R01MH112847, R01MH123563, R01MH113550, R01MH120482, R01MH112847, R01EB022573, RF1MH116920, RF1MH121867, R37MH125829)
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (R34DA050297)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (R01NS060910)
Article History
Received: 10 August 2022
Accepted: 15 February 2023
First Online: 27 March 2023
Competing interests
: The authors declare the following competing interest: R.T.S. receives consulting income from Octave Bioscience for work wholly unrelated to the present research. All other authors declare no competing interests.